Chennai Mayor Inaugurates Dr Agarwal’s Eye Hospital with Advanced Retinal Imaging Technology at Porur
OCT Angiography, the advanced retinal imaging technology introduced at the new hospital, eliminates the usage of dyes for the diagnosis of eye diseases
Smt. R. Priya, Mayor, Greater Chennai Corporation, inaugurated Dr Agarwal’s Eye Hospital, Porur and launched an advanced noninvasive retinal imaging technology, known as AngioPlex OCT Angiography (OCTA), at the hospital. As part of the inaugural celebration, the new hospital will offer free consultations to patients till January 31, 2023.
Thiru Karambakkam K. Ganapathy, MLA, Maduravoyal, participated in the event as guest of honour. Dr. Athiya Agarwal, Director, Dr. Agarwal’s Group of Eye Hospitals, and Dr. Kaladevi Sathish, Zonal Head – Clinical Services, Dr Agarwal’s Eye Hospital, Porur, were also present.
Dr. Agarwal’s Eye Hospital, Porur, houses world class facilities for eye care services including the state-of-art Opticals, pharmacy, and modular Operation Theatre, besides a dedicated myopia screening and a treatment clinic for myopia patients.
The hospital is among a few in the city to have OCTA, a noninvasive and advanced imaging technique that produces high-resolution, 3D angiograms of the retinal and choroidal vascular networks, for effective detection of diseases and abnormalities. OCTA eliminates the usage of dyes in diagnosing eye diseases and thus eliminates the risk of ocular allergic reactions and is safe especially among the patients of cardiovascular and kidney diseases, uncontrollable diabetes, uncontrollable BP, diabetic retinopathy, age-related macular degeneration, and others.
In her inaugural speech, Smt. R. Priya, Mayor, Greater Chennai Corporation said, “Vision health is very important for people, especially the youth, to realize their potential and aspirations – and lead a quality life. However, in the wake of growing exposure to digital screens and changing work and lifestyles, it has become extremely important to create awareness among the public about the importance of availing preventive, curative and rehabilitative eye care services. In this context, I am happy to inaugurate a new wing of Dr. Agarwal’s Eye Hospitals, Porur. The hospital group has been providing world class eye care services at affordable cost to the people of Chennai for decades. I am happy to know that the new hospital at Porur is bringing advanced technologies, including the cutting-edge retinal imaging solution, that will enhance the quality of services offered to patients. I wish all the best for the hospital to grow manifold and touch many more lives by protecting their vision.”
In her address, Dr. Athiya Agarwal, Director, Dr. Agarwal’s Group of Eye Hospitals said, “We are very happy to expand and give a world class eye hospital at Porur. With its advanced facilities and an experienced medical team, this hospital is fully geared up to deliver the highest standards of medical and service excellence and patient care. Dr Agarwal’s Eye Hospital calls Chennai its home, where its first eye care center was started in 1957. Today, we have 18 eye hospitals in the city, including the one in Porur. We are planning to add 10 new hospitals within two years. We keep the reach of world class & innovative eye care and affordability of our services as the two eyes, even as we invest in advanced technologies and expand globally.”
On the facilities at the hospital, Dr. Kaladevi Sathish, Zonal Head – Clinical Services, Dr Agarwal’s Eye Hospital, Porur said, “Our Porur hospital features modern technology and compassionate care, the prerequisites for providing evidence based eyecare and effective treatment outcomes. With OCTA, Dry Eye Clinic, Modular OT, state-of-art opticals and pharmacy a dedicated myopia screening and a treatment clinic for paediatric patients, we bring the promise of scientific advances in eye care to the people of West Chennai.”
Talking about the benefits of OCTA, she said that the technology elevates glaucoma, retinal disease management and treatment planning to the next level, while eliminating the need for the use of fluorescein dye, a diagnostic contrast agent used in various ophthalmic procedures such as checking for any corneal or vessel abnormalities. The dye can lead to ocular allergic reactions such as nausea and vomiting in about 5% of the patients. With OCTA this risk has become a thing of the past. Another key advantage of OCTA is patient comfort as it is a noninvasive procedure that can be done even without dilation